| Term 
 | Definition 
 
        | binds to ribosome, inhibits bacterial protein synthesis. Gram negative.  neomycin-neofradin, streptomycin-streptomycin, gentamycin-garamycin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibit bacterial cell wall synthesis.  broad spectrum.  resist to beta-lactamase enzymes.  ertapenem/invanz, imipenem/primaxin, meropenem/merrem |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits bacterial cell wall synthesis.  related to penicillin.  !st generation effective against gram positive, 2nd & 3rd generation have increased activity against gram-negative oranisms.  4th generation is broad spectrum.  cephalexin/keflex, cefprozil/cefzil, ceftriaxone/rocephin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | new family of antibiotics. binds to 30S ribosome, preventing protein synthesis.  bacteriostatic.  used to treat broad spectrum gram positive, gram-negative, and anaerobic infections.  tigecycline |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | bactericidal.  prevents bacterial ribosomes from translating its mrna into new protein.  used to treat acute bacterial sinusitis, bronchitis, and lung infection |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibit protein synthesis. Bacteriostatic and bactericidal.  used for respiratory, gastrointestinal tract skin and soft tissue infection. Used when penicillin, cephalosporin, and tetracycline are contraindicated.  erthromycin/E-mycin, azithromycin/zithromax, clarithromycin/Biaxin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits cell wall synthesis. significant of penicillinase-resistant penicillins.  used for ear infection, pneumonia, meningitis, urinary infection, syphilis, gonorrhea.   amoxicillin/amoxil, ampicillin/principen, amoxicillin and potassium  clavulanate/ augmentin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibit the growth of bacteria |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | new subclass is used for broad spectrum coverage.  cipro, levaquin |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits protein synthesis, new class developed from pristamycin. quinupristin/dalfopristin. used to resist vancomycin resistant infection |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits bacterial biosynthesis of folic acid resulting in cell death.  used to treat urinary tract infections an d otis media.  used prophylactically in pt susceptible to strep infection or reumatic fever. trimethroprim/sulfamethoxazole/ bactrim |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits protein synthesis. VD, UTI, URTI, pneumonia, and meningitis when penicillin is contraindicated.  tetracycline/sumycin, |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ehambutol/myanbutrol, isoniazid/INH: prevention and treatment, but action unknown.  rifampin/rifadin.  tx fro Tb multifacet & protracted |  | 
        |  | 
        
        | Term 
 
        | gram negative aerobic bacilli from gastrointstinal tract. |  | Definition 
 
        | e coli, staph, pneumonia  also other oranisms enterbacter, proteus mirabilis, pseudomonas aeruginosa |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | fosfomycin/monurol, quinolone, nitofutantoin/macrodantin |  | 
        |  | 
        
        | Term 
 
        | urinary anticholinergic agent |  | Definition 
 
        | oxybutynin/ditrpan, solifenacin/vesicare, tolterodine/detrol |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | neostigmine/prostigmin,  phenazopyridine hydrochloride/pryidium  reddish/orange urine |  | 
        |  | 
        
        | Term 
 
        | opiate agonist, the nursing process includes? |  | Definition 
 
        | premedication assessment and planning & knowledge of antidotes.  Do not administer if respirations below 12. |  | 
        |  | 
        
        | Term 
 
        | opiate agonist expected side effects |  | Definition 
 
        | light-headedness, dizzyness, seation,nausea, sweating, confusion, disorientation, orthostatic hypertension, constipation |  | 
        |  | 
        
        | Term 
 
        | opiate agonist, report these side effects |  | Definition 
 
        | respiratory depression, urinary retension, overabuse, or abuse.  itching-benadryl.  urinaty retention- 30 ml of urine per hr |  | 
        |  | 
        
        | Term 
 
        | opiate agonist, interactions |  | Definition 
 
        | CNS depressants may enhance depressants effect, some enzymes-inducing agents may intereact negatively |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | the optimal potential effect of a med.  once a therapeutic limit is reached, increases in dose may produce side effects but no further beneficial effects. |  | 
        |  | 
        
        | Term 
 
        | what pain management drug classification has ceiling effect? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | opiate partial agonist.  pharmacologic action depend on whether..... |  | Definition 
 
        | an ipiate has been previously administered.  dependence to the opiate agonist exist |  | 
        |  | 
        
        | Term 
 
        | effective analgesic without prior administration of opiate agonists |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | used in presents of opiate dependence, opiate partial agonist will induce wiothdrawal symptoms |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | opiate partiial agonist , nursing process |  | Definition 
 
        | premedication assessment and planning.  check for prior use of opiate agonist. |  | 
        |  | 
        
        | Term 
 
        | opiate partial agonist expected side effects |  | Definition 
 
        | clamminess, dizziness, sedation, nausea, dry mouth, sweating, constipation |  | 
        |  | 
        
        | Term 
 
        | opiate partial agonist, report these side effects |  | Definition 
 
        | confusion, disorientation, hallucination, repiratory depression, overuse, or abuse |  | 
        |  | 
        
        | Term 
 
        | opiate partial agonist, drug interaction |  | Definition 
 
        | CNS depressant, opiate agonists |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | reverse the respiratory depression, sedation, and hypotension associated opiate agonist and opiate partial agonist |  | 
        |  | 
        
        | Term 
 
        | three closely related opiate antagonists are |  | Definition 
 
        | nalmefene, naloxone, naltrexone, narcan.  "pure" opiate antagonist. (no effect on its own other than reversing CNS depressant effect of opiods and propoxyphene.)treat resp depression when excessive doses administered |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | slight to moderate pain.                      analgesic, antipyretic, and antiiflammatory prostaglandin inhibitors conscious level not dulled, memory, sedation |  | 
        |  | 
        
        | Term 
 
        | do not exceed _ grams a day of apap |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | miscellanrous analgesics names |  | Definition 
 
        | darvocet, lortab, percocet, tylenol w codeine, vicodin |  | 
        |  |